Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells.

Drug design, development and therapy2015Zhang LF, Zhou ZW, Wang ZH, et al.

Study designOther primary literature

SubjectAnimal

Record checks

Study design: Other primary literature
Subject: Animal
Publication year: 2015
Source: doi.org
Abstract display: Not reproduced here
Publication status: Retracted
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Flagged

How to read this record →

Publication-status notice

Publication status: Retracted

Europe PMC relationship metadata: retracted_by.

View status evidence →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Amyloid beta-PeptidesAnimalsCaffeineCell SurvivalCoffeeDose-Response Relationship, DrugMelatoninMiceMolecular Docking SimulationProtein Aggregation, PathologicalProtein MultimerizationStructure-Activity RelationshipTumor Cells, Culturedtau Proteins

DOI 10.2147/dddt.s71106

PMID 25565776

View source →